Loading...

DaVita Inc.

0I7E.LLSE
Healthcare
Medical - Equipment & Services
£140.23
£2.91(2.12%)

DaVita Inc. (0I7E.L) Financial Performance & Income Statement Overview

Analyze DaVita Inc. (0I7E.L) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.

Revenue Growth
5.56%
5.56%
Operating Income Growth
30.43%
30.43%
Net Income Growth
35.40%
35.40%
Operating Cash Flow Growth
-1.80%
1.80%
Operating Margin
15.77%
15.77%
Gross Margin
32.46%
32.46%
Net Profit Margin
6.63%
6.63%
ROE
393.58%
393.58%
ROIC
14.39%
14.39%

DaVita Inc. (0I7E.L) Income Statement & Financial Overview

Access detailed annual and quarterly income data for DaVita Inc. 0I7E.L financial performance.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$3.22B$3.29B$3.26B$3.19B
Cost of Revenue$2.24B$2.23B$2.15B$2.14B
Gross Profit$983.87M$1.07B$1.11B$1.04B
Gross Profit Ratio$0.31$0.32$0.34$0.33
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$374.09M$414.48M$393.53M$367.85M
Operating Expenses$544.93M$503.95M$576.84M$538.02M
Total Costs & Expenses$2.78B$2.73B$2.73B$2.68B
Interest Income$0.00$0.00$0.00$0.00
Interest Expense$135.06M$138.72M$134.58M$97.75M
Depreciation & Amortization$176.45M$174.10M$187.01M$175.66M
EBITDA$597.84M$726.56M$695.03M$644.85M
EBITDA Ratio$0.19$0.22$0.21$0.20
Operating Income$438.94M$565.36M$534.88M$506.40M
Operating Income Ratio$0.14$0.17$0.16$0.16
Other Income/Expenses (Net)-$152.60M-$151.63M-$161.44M-$134.96M
Income Before Tax$286.33M$413.73M$373.43M$371.44M
Income Before Tax Ratio$0.09$0.13$0.11$0.12
Income Tax Expense$54.12M$64.49M$77.67M$71.69M
Net Income$162.92M$259.33M$214.69M$222.68M
Net Income Ratio$0.05$0.08$0.07$0.07
EPS$2.05$3.18$2.56$2.56
Diluted EPS$2.00$3.09$2.50$2.50
Weighted Avg Shares Outstanding$79.37M$81.62M$83.72M$86.90M
Weighted Avg Shares Outstanding (Diluted)$81.28M$83.85M$85.80M$88.95M

Over the last four quarters, DaVita Inc.'s revenue moved from $3.19B in Q2 2024 to $3.22B in Q1 2025. Operating income in Q1 2025 was $438.94M, with a strong operating margin of 14%. Despite fluctuations in R&D and SG&A expenses, EBITDA for DaVita Inc. remained robust at $597.84M, reflecting operational efficiency. Net income dropped to $162.92M, with an EPS of $2.05. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;